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Abstract To report the case of a patient initially
diagnosed with acute posterior multifocal placoid
pigment epitheliopathy (APMPPE), characterized by
relentless evolution despite high-dose steroid therapy.
An interferon-gamma release assay (IGRA) indicated
a diagnosis of suspected tuberculous choriocapillaritis
and the disease responded only to massive inflamma-
tion suppressive therapy and antibiotic therapy. Case
report. Review of clinical features and investigational
procedures. Smoldering relentless evolution and
subsequent arrest of progression could be precisely
monitored by indocyanine green angiography (ICGA).
The patient did not recover after standard anti-
tubercolosis (TB) therapy combined with corticoste-
roid. A fourth antibiotic had to be added in order to
stop the progression of the retinal disease. In each case
of choriocapillaritis such as APMPPE an infectious
cause including TB has to be excluded making IGRA
tests unavoidable. As the main structure involved is
the choriocapillaris the most precise follow-up or
monitoring is obtained with ICGA.
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Introduction
Inflammatory diseases of the choriocapillaris (for-
merly called ‘white dot syndromes’) are a spectrum of
conditions including well-known entities such as acute
posterior multifocal placoid pigment epitheliopathy
(APMPPE), multiple evanescent white dot syndrome,
multifocal choroiditis and serpiginous choroiditis (SC)
as well as entities difficult to categorize.
Moreover, clinical presentation of many of these
entities frequently overlap rendering exact categori-
zation difficult. In the literature intermediary forms
between APMPPE and SC have been described. Some
authors called these cases ‘ampiginous choroiditis’ [1]
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and others called them ‘relentless placoid chorioret-
initis’ [2].
Sometimes we come across cases of choriocapilla-
ritis that do not fall into the well-defined categories
cited above. It is of course desirable to classify a case
into these known entities but it is not essential. It is
much more important with choriocapillaritis to be
aware of the disease mechanism (inflammatory cho-
riocapillaris non-perfusion) instead of trying to name
the disease. It is also much more important to establish
the exact extension of lesions for which indocyanine
green angiography (ICGA) is indispensable [3].
Choroidal circulatory status can only be meaning-
fully assessed by ICGA and this imaging modality is the
most suitable to confirm the correct diagnosis. For the
follow-up and monitoring of lesions, however, ICGA is
unavoidable. Here, we report the case of a patient who
was initially diagnosed as suffering from APMPPE and
who received high-dose systemic corticosteroids that
did not arrest the progression of the disease. Only
combined massive anti-tuberculosis (TB) and immuno-
suppressive therapy that was started after receiving a
positive interferon gamma release assay (IGRA) suc-
ceeded in stopping the disease progression.
Case report
A 42-year-old otherwise healthy Caucasian woman
presented to the Centre for ophthalmic specialised care
(COS) in Lausanne, Switzerland with a 4-month
history of halos and decreased vision in the left eye.
Fluorescein angiography (FA) performed elsewhere
was normal in the right eye (RE), while the left eye
(LE) showed patchy early hypofluorescent lesions,
mainly located in the posterior pole, with late leakage
at their borders and the presence of vasculitis. A
diagnosis of APMPPE was put forward by her former
physicians and she received systemic corticosteroids
(3-day 500 mg intravenous methylprednisolone fol-
lowed by oral prednisone 50 mg/day for 2 months
tapered over 4 months to 6.25 mg/day) and antiviral
treatment (valaciclovir 3 g/day for 3 months tapered
over 4 months to 1 g/day).
At presentation at our center, she was still under
systemic corticosteroids (6.25 mg/day) and valaciclo-
vir (1 g/day). Her visual acuity was 20/20 in the RE
and 20/80 in the LE, and intraocular pressure by
Goldmann tonometry was 10 mmHg in both eyes.
Anterior segments were normal but a subclinical
inflammation in the anterior chamber of the LE was
revealed by laser flare photometry (8.7 ph/ms; normal
values 3–6 ph/ms) (Kowa FM-500; Kowa Company
Ltd., Electronics and Optics Division, Tokyo, Japan).
Vitreous cells were absent. Dilated fundus examina-
tion was unremarkable in the RE but the LE showed
multiple yellow-white lesions and some pigmented
scars (Fig. 1A, B). Visual field examination showed a
central relative scotoma in the LE. Optical coherence
tomography (OCT) (OTI-Spectral OCT/SLO; Oph-
thalmic Technologies Inc., Toronto, ON, Canada) was
normal in the RE while the LE showed some
disruption of the retinal pigment epithelium across
the subfoveal area (Fig. 1C, D). Microperimetry was
within normal limits in the RE whereas it was
pathologic in the LE with a visual score of 302/560
(10.8 dB) (normal range 13–19 dB) (Pattern Polar
3–11, Size Goldmann III OTI-Spectral OCT/SLO
microperimetry; OTI Inc.). We performed another FA
which was normal in the RE, while the LE showed
new early hypofluorescent lesions with late hyperflu-
orescence (Fig. 1E, F). ICGA was performed to map
out the exact areas of involvement; the RE was
unremarkable and the LE showed numerous hypoflu-
orescent lesions of different sizes in the early,
intermediate and late frames indicating areas of
chorioretinal scars and/or choriocapillaris non-perfu-
sion (Fig. 1G, H). On ICGA, lesions were more clearly
visible and more well delineated when compared to
lesions on FA.
In addition to the laboratory tests performed at
the onset of disease that were within normal limits,
we performed a IGRA (QuantiFERON-TBTM Gold;
Cellestis, Victoria, Australia) which was strongly
positive (2.52 IU/mL; cut-off value 0.35 IU/mL) in
the setting of a non-vaccinated patient. No intraocular
fluid was sampled and polymerase chain reaction was
not performed, because these examinations are repeat-
edly negative in non-endemic areas. An immune-
mediated choriocapillaritis related to Mycobacterium
tuberculosis was suspected. The patient was referred
to a general physician in order to search for active foci
of extraocular TB which proved negative. A course of
three-drug anti-TB therapy was started (ethambutol
15 mg/kg/day, isoniazid 4 mg/kg/day, rifampicin
10 mg/kg/day) and oral steroids were maintained
and an immunosuppressant (azathioprine 2.5 mg/kg/
day) was added. As the patient did not tolerate
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Fig. 1 Color fundus
photographs at presentation
of the right normal eye
(A) and left affected eye
(B) showing yellowish
multifocal lesions
surrounded by some
pigmented scars. OCT
shows interruptions at the
level of the retinal pigment
epithelium and
inhomogeneous retina
(D) as compared to the right
non-affected eye (C). Late
FA frames (E, F) show
hyperfluorescent lesions.
ICGA (G, H) shows
hypofluorescent areas
indicating chorioretinal
scars and/or choriocapillaris
non-perfusion. There are
more lesions than seen on
FA. These additional lesions
account for new areas of
involvement
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azathioprine because of abdominal pain she was
changed to mycophenolic acid (1,440 mg/daily).
Visual acuity in the LE improved to 20/20 in the
first 2 months of treatment, but new choroidal lesions
appeared on the ICG frames (Fig. 2) and a fourth anti-
TB drug was added (pyrazinamide 20 mg/kg/day).
Four months later the visual acuity remained stable
in the LE but the ICGA showed new active lesions
despite maximal anti-TB therapy (Fig. 2C, D). There-
fore, oral steroids were started again (prednisone
0.5 mg/kg/day).
Two months later, under quadruple anti-TB therapy
combined with mycophenolic acid and oral cortico-
steroid treatment, the patient did not show new lesions
for the first time; her visual acuity remained 20/20 in
the LE, inflammation in the anterior chamber of LE
decreased to 4.7 ph/ms, and the microperimetry
increased to 464/560 (16.6 dB) with almost complete
resolution of the central relative scotoma. ICGA
findings were still negative for new lesions and the
more recent lesions had regressed and were barely
visible anymore and not visible at all on FA (Fig. 3).
The patient remained with no additional lesions at
9 month follow-up.
Discussion
This case is of particular interest because of its
unilaterality and its progressiveness. Therefore this
was an unclassifiable form of choriocapillaritis most
probably due to an immune-mediated choriocapillari-
tis related to TB with clinical features similar to the
cases described by Gupta et al. [4]. Although these
types of ampiginous cases were believed to be purely
immunogenic and normally respond to systemic
corticosteroids and/or immunosuppressants, a differ-
ent form related to TB has been suspected since 1952
[5]. In 2003, Gupta and colleagues found a relation-
ship between TB and conditions resembling APMPPE
and SC in patients from endemic TB areas. They
called these cases serpiginous-like choroiditis and
Fig. 2 Angiographic
frames 2 months after
presentation. FA (A,
B) shows new lesions
(arrows), but ICGA
(C, D) shows new
hypofluorescent lesions
which are much more
widespread (arrows)
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found that the lesions responded to tuberculostatic
drugs along with corticosteroids (TB serpiginous-like
choroiditis). This terminology was recently revised
during the International Ocular Inflammation Society
Congress in November 2011, in Goa, India, where the
terminology ‘multifocal–serpiginous choroiditis’ was
put forward. In our case report we prefer to talk of
‘choriocapillaritis’ instead of ‘choroiditis’ because,
thanks to ICGA, it is obvious that the lesion process is
at the level of the choriocapillaris. The exact patho-
genesis of multifocal–serpiginous choroiditis is
unknown; the choroiditis, or better the choriocapilla-
ritis, may represent a hypersensitivity reaction to a
minimal load of acid-fast bacteria in the choroid that
results in choriocapillaritis with a serpiginous pattern
(multifocal–serpiginous choroiditis) [6]. Multifocal–
serpiginous choroiditis can have two distinct pat-
terns—the classical serpiginous form or multifocal
presentation that resembles APMPPE [4] in its first
stages which is the case here, or a typical serpiginous
pattern or a mixed APMPPE–serpiginous pattern
called ampiginous choroiditis in the past; these lesions
reveal a relentless progression despite administration
of systemic corticosteroids and immunosuppressants.
The combination of anti-TB treatment seems to be the
only way of stopping progression of recurrences. In
our case quadruple anti-TB and immunosuppressive
therapy did not completely stop the disease progres-
sion which was achieved only when corticosteroids
were re-added.
The case presented here is particularly interesting
since a TB component was demonstrated in a patient
from a non-endemic region. Moreover arrest could be
obtained only when optimal combination of inflam-
mation suppressive therapy and anti-TB therapy was
reached.
In this case the essential contribution of ICGA is
very well demonstrated as it showed many more
lesions and increased extension of lesions than seen on
FA and their regression showing the impact on therapy.
In conclusion SC is a more morphological diagno-
sis and should be considered as TB until proven
otherwise even in non-endemic countries. Nowadays
we have the diagnostic means to rule out TB, using
IGRA tests. Immunosuppression alone should only be
given once the TB component has been excluded.
Fig. 3 Angiographic
findings in the healed stage.
FA (A, B) showing late
hyperfluorescence caused
by retinal pigment
epithelium atrophy (window
effect). ICGA (C, D) shows
only cicatricial lesions; the
new lesions, well identified
in Figs 1 and 2, are barely
visible anymore (arrows)
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